Clinical Trials Directory

Trials / Terminated

TerminatedNCT01535404

Right Versus Left Apical Transvenous Pacing for Patients With Preserved Left Ventricular Systolic Function Study

Right Versus Left Apical Transvenous Pacing for Patients With Preserved Left Ventricular Systolic Function (RIVELA) Study

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
36 (actual)
Sponsor
Haran Burri, MD · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare chronic (1-year) effects on left ventricular ejection fraction resulting from transvenous pacing of the right ventricular apex (RVA) versus the left ventricular apex (LVA) in patients with preserved or mildly reduced left ventricular systolic function (\>= 45%).

Detailed description

It is well established that chronic right ventricular apical pacing has an adverse effect on left ventricular systolic function. An alternative is pacing the left ventricular apex, which has shown more favourable results in terms of left ventricular pump function than the RVA in small series. The left ventricular apex may be paced via the coronary sinus tributary (e.g. in the anterior cardiac vein). Our study will compare effects of these two pacing sites on left ventricular ejection fraction measured by 3D-echocardiography.

Conditions

Interventions

TypeNameDescription
DEVICEImplantation procedure for a St-Jude Medical pacemaker system with right ventricular apex pacingImplantation procedure for a St-Jude Medical pacemaker system with a transvenous ventricular and if applicable a right atrial lead
DEVICEImplantation procedure for a St-Jude Medical pacemaker system with left ventricular apex pacingImplantation procedure for a St-Jude Medical pacemaker system with a transvenous left ventricular (coronary sinus) and if applicable a right atrial lead

Timeline

Start date
2012-01-01
Primary completion
2016-05-01
Completion
2016-05-01
First posted
2012-02-17
Last updated
2016-05-13

Locations

6 sites across 2 countries: Netherlands, Switzerland

Source: ClinicalTrials.gov record NCT01535404. Inclusion in this directory is not an endorsement.